These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 37886848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M, Farghaly S, Abdelkawi IF.
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
    Elshetry ASF, El-Fawakry RM, Hamed EM, Metwally MI, Zaid NA.
    Eur J Radiol; 2022 Jun; 151():110282. PubMed ID: 35381566
    [Abstract] [Full Text] [Related]

  • 6. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Arita Y, Shigeta K, Akita H, Suzuki T, Kufukihara R, Kwee TC, Ishii R, Mikami S, Okuda S, Kikuchi E, Oya M, Jinzaki M.
    Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418
    [Abstract] [Full Text] [Related]

  • 7. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y, Kwee TC, Woo S, Shigeta K, Ishii R, Okawara N, Edo H, Waseda Y, Vargas HA.
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer.
    Meng X, Hu H, Wang Y, Feng C, Hu D, Liu Z, Kamel IR, Li Z.
    J Magn Reson Imaging; 2022 Aug; 56(2):391-398. PubMed ID: 35049074
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Onay A, Vural M, Armutlu A, Ozel Yıldız S, Kiremit MC, Esen T, Bakır B.
    Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
    James N, Pirrie S, Liu W, Catto J, Jefferson K, Patel P, Hughes A, Pope A, Nanton V, Mintz HP, Knight A, Gallagher J, Bryan RT.
    Health Technol Assess; 2024 Aug; 28(42):1-65. PubMed ID: 39246267
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.
    Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K.
    Eur Radiol; 2011 Oct; 21(10):2178-86. PubMed ID: 21688007
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Hagen F, Norz V, Thaiss WM, Mair A, Rausch S, Bedke J, Nikolaou K, Stenzl A, Kruck S, Hepp T, Kaufmann S, Estler A.
    Eur J Radiol; 2022 Jan; 146():110059. PubMed ID: 34839167
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.
    Zhang X, Guo J, Yun Y, Shan D, Yang D, Xu C, Chen X.
    Acad Radiol; 2024 Oct; 31(10):4076-4084. PubMed ID: 38548534
    [Abstract] [Full Text] [Related]

  • 20. Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    Gong Y, Cheng Y, Zhang J, Bao ML, Zhu FP, Sun XY, Zhang YD.
    J Magn Reson Imaging; 2024 Sep; 60(3):1113-1123. PubMed ID: 38258496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.